Published in N Engl J Med on December 08, 2005
Case 37-2005: a man with cardiac arrest while sleeping. N Engl J Med (2006) 0.75
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27
Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet (2004) 3.88
Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet (2009) 3.80
Genome-wide association study of PR interval. Nat Genet (2010) 3.73
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation (2009) 3.50
Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm (2007) 3.23
Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc (2013) 2.47
P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study). Am J Cardiol (2011) 2.39
Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation (2011) 2.36
Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation (2010) 2.32
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol (2006) 2.29
Adenosine for wide-complex tachycardia: efficacy and safety. Crit Care Med (2009) 2.10
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J (2009) 2.06
N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation (2009) 1.99
RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med (2012) 1.97
Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation (2010) 1.90
European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation (2010) 1.90
Mutation in the S3 segment of KCNQ1 results in familial lone atrial fibrillation. Heart Rhythm (2009) 1.87
Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy. Heart Rhythm (2011) 1.85
In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am J Physiol Heart Circ Physiol (2006) 1.77
Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. JAMA (2010) 1.75
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72
Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol (2010) 1.70
Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet (2006) 1.68
Cardiac sodium channel gene variants and sudden cardiac death in women. Circulation (2007) 1.67
Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation (2012) 1.67
Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm (2010) 1.66
Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling. Circulation (2012) 1.65
Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery. Circ Cardiovasc Genet (2009) 1.59
Lack of replication in polymorphisms reported to be associated with atrial fibrillation. Heart Rhythm (2010) 1.58
Identification of a Kir3.4 mutation in congenital long QT syndrome. Am J Hum Genet (2010) 1.57
ACE I/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural heart disease: implications for electrical remodeling. Heart Rhythm (2009) 1.55
Genome-wide association studies of the PR interval in African Americans. PLoS Genet (2011) 1.53
Genome-wide association studies in cardiac electrophysiology: recent discoveries and implications for clinical practice. Heart Rhythm (2010) 1.45
Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004. Ann Emerg Med (2007) 1.41
Unpredictable battery depletion of St Jude Atlas II and Atlas+ II HF implantable cardioverter-defibrillators. Heart Rhythm (2011) 1.38
P wave indices: current status and future directions in epidemiology, clinical, and research applications. Circ Arrhythm Electrophysiol (2009) 1.35
Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation. Circulation (2012) 1.32
Genome-wide association studies of atrial fibrillation: past, present, and future. Cardiovasc Res (2011) 1.27
Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation (2012) 1.26
White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study). Am J Cardiol (2011) 1.22
Overexpression of KCNN3 results in sudden cardiac death. Cardiovasc Res (2013) 1.21
Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation (2012) 1.17
Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation. Am J Cardiol (2012) 1.17
Factors affecting error in integration of electroanatomic mapping with CT and MR imaging during catheter ablation of atrial fibrillation. J Interv Card Electrophysiol (2007) 1.17
Genetics of atrial fibrillation. Heart Fail Clin (2010) 1.15
Clinical subtypes of lone atrial fibrillation. Pacing Clin Electrophysiol (2005) 1.12
P-wave indices, distribution and quality control assessment (from the Framingham Heart Study). Ann Noninvasive Electrocardiol (2010) 1.12
Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation (2014) 1.11
A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 1.09
P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and Nutrition Examination Survey. Heart Rhythm (2010) 1.09
Atrial fibrillation in congestive heart failure. Heart Fail Clin (2010) 1.07
Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project. Circ Cardiovasc Genet (2011) 1.06
Catheter ablation of peri-AV nodal atrial tachycardia from the noncoronary cusp of the aortic valve. J Cardiovasc Electrophysiol (2007) 1.02
MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism. J Transl Med (2011) 1.01
Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association. Circulation (2013) 1.01
Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen. Circulation (2010) 1.01
Genetics of atrial fibrillation: implications for future research directions and personalized medicine. Circ Arrhythm Electrophysiol (2010) 1.01
Ion channel mutations in AF: signal or noise? Heart Rhythm (2008) 0.99
Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: A meta-analysis. Heart Rhythm (2011) 0.98
Electrocardiographic PR interval and adverse outcomes in older adults: the Health, Aging, and Body Composition study. Circ Arrhythm Electrophysiol (2012) 0.98
American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association. Circulation (2011) 0.97
Novel loci associated with PR interval in a genome-wide association study of 10 African American cohorts. Circ Cardiovasc Genet (2012) 0.97
Genetics of atrial fibrillation. Cardiol Clin (2009) 0.96
Emerging directions in the genetics of atrial fibrillation. Circ Res (2014) 0.96
Aging syndrome genes and premature coronary artery disease. BMC Med Genet (2005) 0.95
Next steps in cardiovascular disease genomic research--sequencing, epigenetics, and transcriptomics. Clin Chem (2011) 0.95
Monogenic atrial fibrillation as pathophysiological paradigms. Cardiovasc Res (2010) 0.94
Impact of ancestry and common genetic variants on QT interval in African Americans. Circ Cardiovasc Genet (2012) 0.94
Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study. Am Heart J (2011) 0.94
Risk assessment for incident heart failure in individuals with atrial fibrillation. Eur J Heart Fail (2013) 0.94
The QT interval and risk of incident atrial fibrillation. Heart Rhythm (2013) 0.93
Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials. Eur J Heart Fail (2010) 0.90
Vitamin D status is not related to development of atrial fibrillation in the community. Am Heart J (2011) 0.89
Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community. J Am Heart Assoc (2013) 0.88
Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study. Circ Arrhythm Electrophysiol (2014) 0.87
Influence of race on atrial fibrillation after cardiac surgery. Circ Arrhythm Electrophysiol (2011) 0.87
A Novel Transgenic Mouse Model of Cardiac Hypertrophy and Atrial Fibrillation. J Atr Fibrillation (2012) 0.86
Myocardial blood flow and oxygen consumption in patients with Friedreich's ataxia prior to the onset of cardiomyopathy. Coron Artery Dis (2007) 0.86
The impact of new and emerging clinical data on treatment strategies for atrial fibrillation. J Cardiovasc Electrophysiol (2010) 0.86
P-wave indices: derivation of reference values from the Framingham Heart Study. Ann Noninvasive Electrocardiol (2010) 0.86
Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association. Circulation (2016) 0.86
Reciprocal relations between physical disability, subjective health, and atrial fibrillation: the Framingham Heart Study. Am Heart J (2013) 0.85
Stroke risk in AF: do AF patterns matter? Eur Heart J (2010) 0.84
Evaluation of non-synonymous NPPA single nucleotide polymorphisms in atrial fibrillation. Europace (2010) 0.84
New advances in the genetic basis of atrial fibrillation. J Cardiovasc Electrophysiol (2012) 0.84
Insulin resistance and atrial fibrillation (from the Framingham Heart Study). Am J Cardiol (2011) 0.83
The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry. Circ Heart Fail (2009) 0.83
Challenges in the classification of atrial fibrillation. Nat Rev Cardiol (2010) 0.83
Elevation of parathyroid hormone levels in atrial fibrillation. J Am Coll Cardiol (2011) 0.83
Age of natural menopause and atrial fibrillation: the Framingham Heart Study. Am Heart J (2012) 0.83
Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison. Acad Emerg Med (2010) 0.83
A meta-analysis of genome-wide association studies of the electrocardiographic early repolarization pattern. Heart Rhythm (2012) 0.81